Moringa Salmonella Recalls: Products and Final Outbreak Facts
Updated: Oct 6
Reviewed and updated October 6, 2026.
Federal investigators handled three separate 2025–2026 Salmonella outbreaks involving moringa leaf powder. All three investigations are now closed. The recalled products, however, include powders and capsules with expiration dates extending into 2028.
That is why the useful question is no longer whether an outbreak is “active.” It is whether a recalled bottle or pouch is still in a kitchen cabinet. Consumers should identify the exact brand, product, lot, and expiration date on FDA’s current pages rather than rely on a headline or assume that every moringa product was recalled.
Three investigations, not one combined recall
The events involved different products, outbreak strains, and final counts.
Live it Up, Why Not Natural, TNVitamins, and Doctor’s Pride
CDC’s final July 22 update reported:
131 illnesses in 38 states;
36 hospitalizations among 121 people for whom that information was available;
no deaths; and
illness onsets from August 22, 2025 through June 14, 2026.
The investigation involved Salmonella Typhimurium, Newport, and Richmond infections linked to recalled products containing moringa leaf powder. The recalled products included certain Live it Up Super Greens powders, Why Not Natural moringa capsules, TNVitamins products, and Doctor’s Pride products.
Some affected lots have expiration dates in 2027 or 2028. CDC therefore continues to tell consumers to check their homes even though the outbreak is over.
Rosabella moringa capsules
FDA’s final Rosabella investigation page reports:
10 illnesses in eight states;
three hospitalizations;
no deaths; and
nationwide and international distribution.
An unopened product sample from a sick person’s home contained the outbreak strain. The Salmonella Newport and Kentucky strains associated with this outbreak were resistant to the first-line and alternative antibiotics commonly recommended for treating Salmonella infections.
Ambrosia Brands recalled specified Rosabella lots on February 13, 2026. FDA’s page lists the affected codes and expiration dates. Consumers should use that table rather than assume that every Rosabella product has the same status.
MOGO moringa capsules
FDA’s final MOGO investigation page reports:
34 illnesses;
11 hospitalizations among 25 people for whom that information was available;
no deaths; and
a last reported illness onset of June 21, 2026.
The recall covers MOGO Pure Moringa Oleifera capsules in:
lot 15525AA, expiration June 2027; and
lot 00926AA, expiration January 2028.
State investigators found the outbreak strain in opened MOGO containers collected from sick people’s homes. FDA also reported inspection observations at the ingredient supplier and manufacturer and increased screening of imported moringa powder from India.
Why the old headline needed correction
Earlier public counts changed while the investigations were open. The large CDC investigation grew from 119 reported illnesses to a final 131. The MOGO count grew from 18 to 34. Treating an interim number as permanent would leave readers with a precise but wrong answer.
The same is true of product lists. Later recalls added products and lots. A current guide should point readers to the live government tables because those tables—not a summary written months earlier—control the product match.
Where Alabama fits
The final government pages reviewed for this update do not list a confirmed Alabama illness. Several implicated products were sold through nationwide websites and online marketplaces, and some had nationwide distribution. That establishes a route by which products could reach Alabama; it does not establish an Alabama case.
The distinction is important. A national distribution statement is evidence about where a product was offered or shipped. It is not proof that a specific Alabama household bought a recalled lot or that a particular illness came from it.
What consumers should do
Stop using a product that matches an official recall. Do not judge safety by appearance, taste, or smell.
Match the full identifier. Check the brand, product name, lot code, expiration date, and package size against the appropriate FDA or CDC page.
Follow the stated return or disposal instructions. Do not give a recalled product to someone else.
Clean affected surfaces and containers. FDA advises careful cleaning to reduce cross-contamination.
Seek medical care for possible illness. Tell the provider the exact supplement and recall involved. This is especially important for the drug-resistant Rosabella outbreak.
Preserve useful proof. Photograph the label and code, retain purchase records, and keep a dated account of use and symptoms. Do not postpone medical care to collect documentation.
A recall does not prove an individual claim
The government findings establish that identified products were associated with outbreaks. An individual legal claim may still require proof of the exact product and lot, exposure, diagnosis, timing, other possible causes, and resulting losses.
The supplier chain can also matter. The brand on the bottle may differ from the company that processed, imported, or supplied the moringa ingredient. Those relationships should be established from records, not assumed from a label.
For a broader explanation, read Product Liability and the AEMLD in Alabama.
Frequently asked questions
Are the moringa outbreaks still active?
No. CDC and FDA say all three investigations discussed here are over or complete. Recalled products may still be in homes because several expiration dates extend into 2027 or 2028.
Were 119 people affected?
That was an interim count for one of the investigations. CDC’s final count for that outbreak is 131 illnesses in 38 states. The separate Rosabella and MOGO investigations had their own counts.
Was every moringa supplement recalled?
No. The notices identify particular brands, products, lots, and dates. Use the official tables to match the package in hand.
Did these outbreaks include Alabama?
The final government pages reviewed for this article do not identify a confirmed Alabama illness. Nationwide and online distribution means Alabama consumers may nevertheless possess affected products.
Why should the original package be kept?
The brand, lot, expiration date, and package details distinguish a recalled product from one outside the notice. Those identifiers can also help a health department, physician, retailer, or attorney evaluate what happened.
Primary sources
Discuss an Alabama product-injury matter
If an Alabama consumer was diagnosed with a serious illness after using a recalled supplement, the Law Offices of Elliott Owen Lipinsky can review the facts and explain a practical next step. Call (334) 230-7986 or request a free case review.
This article provides general information, not legal or medical advice. Recall information can change; use the linked government pages for current product instructions. Contacting the firm does not create an attorney-client relationship. Representation begins only after the firm accepts a matter in writing. Do not send medical records, confidential information, or time-critical material through a website form.
